GSK says AI is reshaping drug pipeline as Nuvalent deal hits shares

https://www.cityam.com/wp-content/uploads/2024/07/gsk-getty-57ff73d48ba8f-57ff73d497e8c.webp?w=1107" />

GSK has said agentic AI is already affecting every asset in its pipeline, as pharmaceutical firms race to use the technology to cut the cost and risk of developing new medicines.

Speaking at London Tech Week in Tuesday, Eyal Itskovitz, GSK’s director of AI and machine learning, said that the technology has officially become a https://www.cityam.com/gsk-says-ai-is-reshaping-drug-pipeline-as-nuvalent-deal-hits-shares/">[...]